CHANGCHUN, China and LOS ANGELES, July 21 /PRNewswire-Asia/ -- China Yongxin Pharmaceuticals Inc. (OTC Bulletin Board: CYXN) ("China Yongxin" or the "Company"), one of the leading health products distribution and retail sales companies in China, today announced the opening of seven new chain drugstores in July. These new openings bring the Company's number of stores to 30 in Changchun City, 31 in Baishan City, and a total of 110 throughout Northeastern China. The Company has expedited the pace of store openings in order to reach its previously announced goal of opening 29 stores in 2010. The Company's objective is to become one of the top 20 pharmaceutical retail chain enterprises in China.
China Yongxin held grand opening ceremonies in July for all six new stores in Changchun City, which is expected to further increase awareness of the China Yongxin brand in the community. These six locations were chosen for their strategic locations in high density and high income residential districts. The Lin He Street store is located on the beautiful River of Life that runs through Changchun City, also known for its heavy foot traffic. The Jian Min Street store is located in the "My Home" district, adjacent to the Royal Emerald Palace upscale community. The Fei Yue Road store is located in the core of China FAW Group district, which has a large residential community with a high population density. The De Chang Road store is located in the Hongqi Street shopping district, adjacent to the Hospital of Jilin Province. The Chang Da Road and Cambridge Park stores are located near the Changchun University and Jilin University, respectively, allowing the Company to access the universities' large student populations and surrounding residents. The seventh store is located in Baishan City, adding an additional store to the Bai Shan Cao An Tang brand.
The new drugstores provide customers with a wide range of over-the-counter Chinese traditional and Western medicines, prescription pharmaceuticals, natural health products including herbal and nutritional supplements, health foods, personal care products and cosmetics. These stores will also provide customers that are located within close proximity with free delivery services, which management believes may be a cost-effective method of attracting more customers and increasing sales.
According to Mr. Yongxin Liu, Chairman and CEO, "We are pleased to announce the opening of a total of 13 new stores in 2010, expanding our footprint within densely populated and high income districts. We continue to be confident that we will reach our projected goals for 2010 and become the largest drugstore chain in Northeastern China," Mr. Yongxin Liu added.
About China Yongxin Pharmaceuticals Inc.
Founded in 1993, China Yongxin Pharmaceuticals is one of the leading retailers and distributors of over-the-counter Chinese traditional and Western medicines, prescription pharmaceuticals, natural health products including herbal and nutritional supplements, health foods, personal care products, cosmetics and medical equipment in Northeastern China. Its retail operations began in 2004, and in 2005, it gained franchise rights from one of the world's largest drug chains for China's Jilin Province.
The Company had become one of the fastest growing drug retailers in China through its retail chain of 110 drug outlets as well as its wholesale distribution in Northeastern China. For more information about China Yongxin Pharmaceuticals Inc., please visit http://www.yongxinchina.com .
Forward Looking Statements
This news release contains certain "forward-looking statements." Forward- looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," "project", "expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceuticals Inc. does not assume any duty to publicly update or revise the material contained herein.
For more information, please contact: CORPORATE China Yongxin Pharmaceuticals Inc. Sam Liu, Chief Operating Officer Tel: +1-626-581-9098 Email: firstname.lastname@example.org INVESTOR RELATIONS Strategic Growth International, Inc. Richard Cooper, Chairman Tel: +1-212-838-1444 Email: email@example.com
|SOURCE China Yongxin Pharmaceuticals Inc.|
Copyright©2010 PR Newswire.
All rights reserved